Catalog No. |
TD-HF998066 |
Species reactivity |
Human |
Applications |
Research Grade Biosimilar |
Host species |
Chimeric |
Isotype |
IgG1-lambda |
Expression system |
Mammalian Cells |
Species |
Human |
Clonality |
Monoclonal |
Target |
T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4 |
Endotoxin level |
Please contact with the lab for this information. |
Purity |
>95% as determined by SDS-PAGE. |
Purification |
Protein A/G purified from cell culture supernatant. |
Accession |
P01730 |
Form |
Liquid |
Storage buffer |
0.01M PBS, pH 7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternate Names |
IDEC CE9.1/SB-210396, CAS: 174722-30-6 |
Background |
Keliximab (SB-210396) is a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody with a Ki value of 1.0 nM for soluble CD4. Keliximab blocks T cell proliferation and inhibits IL-2 production. Keliximab can be used for cancer research. |
Note |
For research use only. Not suitable for clinical or therapeutic use. |